Ligand to acquire XOMA Royalty for $739 million in cash deal
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced it will acquire XOMA Royalty Corporation (NASDAQ: XOMA) for $39.00 per share in cash ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)